Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Graphite Bio Inc (NQ: GRPH )

2.970 +0.050 (+1.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 106,973
Open 2.940
Bid (Size) 2.790 (1)
Ask (Size) 3.070 (1)
Prev. Close 2.920
Today's Range 2.870 - 2.970
52wk Range 1.590 - 4.480
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial Results
From Graphite Bio, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
 
Via Benzinga

Performance

YTD
-7.48%
-7.48%
1 Month
-8.97%
-8.97%
3 Month
+17.86%
+17.86%
6 Month
-17.27%
-17.27%
1 Year
+24.27%
+24.27%

More News

Read More
Graphite Bio Announces Process to Explore Strategic Alternatives and Corporate Restructuring
From Graphite Bio, Inc.
Via Business Wire
Expert Ratings for Graphite Bio
Via Benzinga
Graphite Bio Shares Tank After Pausing Sickle Cell Therapy Study
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023
Via Benzinga
Top 5 Health Care Stocks That May Surge
Via Benzinga
Looking Into Graphite Bio's Recent Short Interest
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
Via Benzinga
Dow Jumps 700 Points; S&P 500 Rises Over 2%
Via Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Dow Rises Over 300 Points; US Adds 223,000 Jobs In December
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Graphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell Disease
From Graphite Bio, Inc.
Via Business Wire
Graphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual Meeting
From Graphite Bio, Inc.
Via Business Wire
Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference
From Graphite Bio, Inc.
Via Business Wire
Graphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial Results
From Graphite Bio, Inc.
Via Business Wire
Graphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and Exposition
From Graphite Bio, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.